U.S., Sept. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07817537) titled 'Evaluating the Effectiveness of Intramuscular Versus Intravenous Tranexamic Acid for Minimizing Blood Loss After Total Hip Arthroplasty: A Randomized Controlled Trial' on July 12.

Brief Summary: Intramuscular vs. Intravenous Tranexamic Acid for Total Hip Arthroplasty

Study Start Date: Jan. 15

Study Type: INTERVENTIONAL

Condition: Blood Loss After a Total Hip Replacement

Intervention: DRUG: Tranexamic Acid (TXA) intarmuscular

Tranexamic acid 1 gram administered via deep intramuscular injection into the lateral thigh or deltoid muscle prior to surgery.

DRUG: Tranexamic Acid (TXA) intravenous

Tranexamic acid 1 gram administer...